Cargando…

Attitudes of Clinicians Following Large-Scale Pharmacogenomics Implementation

Clinician attitudes towards multiplexed genomic testing may be vital to the success of translational programs. We surveyed clinicians at an academic medical center about their views on a large pharmacogenomics implementation, the PREDICT (Pharmacogenomic Resource for Enhanced Decisions in Care &...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peterson, Josh F., Field, Julie R., Shi, Yaping, Schildcrout, Jonathan S., Denny, Joshua C., McGregor, Tracy L., Van Driest, Sara L., Pulley, Jill M., Lubin, Ira M., Laposata, Michael, Roden, Dan M., Clayton, Ellen W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751074/ https://www.ncbi.nlm.nih.gov/pubmed/26261062 http://dx.doi.org/10.1038/tpj.2015.57

Ejemplares similares

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing
por: Van Driest, Sara L., et al.
Publicado: (2013)

Developing Pharmacogenomic Reports: Insights from Patients and Clinicians
por: Jones, Laney K., et al.
Publicado: (2018)

A Decision-Theoretic Approach to Panel-Based, Preemptive Genotyping
por: Shi, Yaping, et al.
Publicado: (2019)

Genome‐wide and Phenome‐wide Approaches to Understand Variable Drug Actions in Electronic Health Records
por: Robinson, Jamie R., et al.
Publicado: (2017)

Integrating EMR-Linked and In Vivo Functional Genetic Data to Identify New Genotype-Phenotype Associations
por: Mosley, Jonathan D., et al.
Publicado: (2014)

Frequency of benign neutropenia among Black versus White individuals undergoing a bone marrow assessment
por: Borinstein, Scott C., et al.
Publicado: (2022)

Wearable technologies in osteoarthritis: a qualitative study of clinicians’ preferences
por: Papi, Enrica, et al.
Publicado: (2016)

Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer
por: Lu, Christine Y., et al.
Publicado: (2018)

We’re not all cut from the same cloth: TAILORing treatments for children with chronic conditions
por: Jerome, Rebecca N., et al.
Publicado: (2019)

Pharmacogenomics in epilepsy
por: Balestrini, Simona, et al.
Publicado: (2018)

Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota
por: Zhang, Lusi, et al.
Publicado: (2022)

Pharmacogenomics of chemotherapeutic susceptibility and toxicity
por: Moen, Erika L, et al.
Publicado: (2012)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics
Publicado: (2008)

PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations
por: Denny, Joshua C., et al.
Publicado: (2010)

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2016)

Perceived Effect of Socket Fit on Major Lower Limb Prosthetic Rehabilitation: A Clinician and Amputee Perspective
por: Turner, Shruti, et al.
Publicado: (2020)

Acute kidney injury risk-based screening in pediatric inpatients: A pragmatic randomized trial
por: Van Driest, Sara L., et al.
Publicado: (2019)

251 A Mixed Methods Study of Patient and Clinician Views and Experiences of Pharmacogenomic Testing for Major Depressive Disorder
por: Hendy, Katherine, et al.
Publicado: (2023)

Update on the pharmacogenomics of pain management
por: Kaye, Alan David, et al.
Publicado: (2019)

Exploring the clinical context of adopting an instrumented insole: a qualitative study of clinicians’ preferences in England
por: Lin, Denise, et al.
Publicado: (2019)

SI unit conversion guide
por: Laposata, Michael
Publicado: (1992)

Why have doctors stopped asking for autopsies? Will a different type of autopsy change this?
por: Laposata, Michael
Publicado: (2017)

Insufficient Teaching of Laboratory Medicine in US Medical Schools
por: Laposata, Michael
Publicado: (2016)

Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2017)

Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study
por: Oshikoya, Kazeem A., et al.
Publicado: (2019)

Clinician’s attitude towards clozapine prescription
por: Brugue, O., et al.
Publicado: (2023)

Physicians’ Knowledge, Attitude, and Experience of Pharmacogenomic Testing in China
por: Jia, Tong, et al.
Publicado: (2022)

Pharmacogenomics arrives
por: Petsko, Gregory A
Publicado: (2004)

Pharmacogenomic Biomarkers
por: Kirkwood, Sandra C., et al.
Publicado: (2002)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

Pharmacogenomics in Practice
por: Wang, Liewei, et al.
Publicado: (2019)

Pharmacogenomics and Morphine
por: Ofoegbu, Adaku, et al.
Publicado: (2021)

Training emergency physicians in sex- and gender-based medicine: assessing attitudes of program directors and residency graduates
por: Madsen, Tracy E., et al.
Publicado: (2016)

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity
por: McEvoy, L., et al.
Publicado: (2021)

Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support
por: Overby, Casey Lynnette, et al.
Publicado: (2010)

Emerging strategies and applications of pharmacogenomics
por: Milos, Patrice M, et al.
Publicado: (2004)

Is there a role of pharmacogenomics in Africa
por: Matimba, A., et al.
Publicado: (2016)

Pharmacogenomics in the era of personalised medicine
por: White, Cassandra, et al.
Publicado: (2022)

Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders
por: Ratter-Rieck, Jacqueline M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i7bekfcsmpml8pdo3lsvi1itat